Volume 13; Issue 2

Main
Breast Cancer Research
Volume 13; Issue 2

Breast Cancer Research

Volume 13; Issue 2

1

Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer

Bethany N Hannafon, Paola Sebastiani, Antonio de las Morenas, Jining Lu, Carol L Rosenberg

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.42 MB

english, 2011

2

Impact of oncogenicK-RASon YB-1 phosphorylation induced by ionizing radiation

Mahmoud Toulany, Tim-Andre Schickfluß, Wolfgang Eicheler, Rainer Kehlbach, Birgit Schittek, H Peter Rodemann

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 2.36 MB

english, 2011

3

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

Yvonne Hui-Fang Teng, Wai-Jin Tan, Aye-Aye Thike, Poh-Yian Cheok, Gary Man-Kit Tse, Nan-Soon Wong, George Wai-Cheong Yip, Boon-Huat Bay, Puay-Hoon Tan

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.06 MB

english, 2011

4

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity

Karolina Lindberg, Luisa A Helguero, Yoko Omoto, Jan-Åke Gustafsson, Lars-Arne Haldosén

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 3.41 MB

english, 2011

5

Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management

Stéphanie Gaillard, Vered Stearns

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 216 KB

english, 2011

6

ERBB receptors in cancer: signaling from the inside

Carlos L Arteaga

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 129 KB

english, 2011

7

Signaling pathways in breast cancer metastasis - novel insights from functional genomics

Mario Andres Blanco, Yibin Kang

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 193 KB

english, 2011

8

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Cesar G Sanchez, Cynthia X Ma, Robert J Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Li Lin, Matthew J Ellis

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 2.33 MB

english, 2011

9

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

Bhumsuk Keam, Seock-Ah Im, Kyung-Hun Lee, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Se-Hoon Lee, Wonshik Han, Dong-Wan Kim, Tae-You Kim, In Ae Park, Dong-Young Noh, Dae Seog Heo, Yung-Jue Bang

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 542 KB

english, 2011

10

Therapeutic targets for bone metastases in breast cancer

Philippe Clézardin

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 617 KB

english, 2011

11

Stress and breast cancer: from epidemiology to molecular biology

Lilia Antonova, Kristan Aronson, Christopher R Mueller

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.50 MB

english, 2011

12

Alternative TFAP2A isoforms have distinct activities in breast cancer

Chiara Berlato, KaYi V Chan, Anna M Price, Monica Canosa, Angelo G Scibetta, Helen C Hurst

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 989 KB

english, 2011

13

Cell fate takes a slug inBRCA1-associated breast cancer

Geoffrey J Lindeman, Jane E Visvader

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 130 KB

english, 2011

14

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

Ola Blixt, Deanna Bueti, Brian Burford, Diane Allen, Sylvain Julien, Michael Hollingsworth, Alex Gammerman, Ian Fentiman, Joyce Taylor-Papadimitriou, Joy M Burchell

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 2.40 MB

english, 2011

15

Pro-oncogenePokemonpromotes breast cancer progression by upregulatingsurvivinexpression

Xuyu Zu, Jun Ma, Hongxia Liu, Feng Liu, Chunyan Tan, Lingling Yu, Jue Wang, Zhenhua Xie, Deliang Cao, Yuyang Jiang

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 5.44 MB

english, 2011

16

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

Xianglin Wu, Malayannan Subramaniam, Sarah B Grygo, Zhifu Sun, Vivian Negron, Wilma L Lingle, Matthew P Goetz, James N Ingle, Thomas C Spelsberg, John R Hawse

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.74 MB

english, 2011

17

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

Iain R Hutcheson, Lindy Goddard, Denise Barrow, Richard A McClelland, Hayley E Francies, Janice M Knowlden, Robert I Nicholson, Julia MW Gee

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.23 MB

english, 2011

18

More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response

Xiaoyong Fu, Catherine Huang, Rachel Schiff

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 132 KB

english, 2011

19

Loss ofBRCA1leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers inBRCA1-mutant mice

Laura N Burga, Hai Hu, Ashish Juvekar, Nadine M Tung, Susan L Troyan, Erin W Hofstatter, Gerburg M Wulf

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 4.42 MB

english, 2011

20

Stratifying triple-negative breast cancer: which definition(s) to use?

Barbara Adamo, Carey K Anders

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 168 KB

english, 2011

21

Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase

Elaine A McSherry, Kieran Brennan, Lance Hudson, Arnold DK Hill, Ann M Hopkins

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.98 MB

english, 2011

22

Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator

Wonchung Lim, Yeomyung Park, Jungyoon Cho, Choa Park, Joonwoo Park, Young-Kwon Park, Hyunsung Park, YoungJoo Lee

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 917 KB

english, 2011

23

The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines

Mauro De Santi, Luca Galluzzi, Simone Lucarini, Maria Filomena Paoletti, Alessandra Fraternale, Andrea Duranti, Cinzia De Marco, Mirco Fanelli, Nadia Zaffaroni, Giorgio Brandi, Mauro Magnani

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.29 MB

english, 2011

24

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study

Sang Woo Oh, Cheol-Young Park, Eun Sook Lee, Yeong Sook Yoon, Eon Sook Lee, Sang Shin Park, Yuil Kim, Nak Jin Sung, Young Ho Yun, Keun Seok Lee, Han Sung Kang, Youngmee Kwon, Jungsil Ro

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.24 MB

english, 2011

25

Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer

Ali Naderi, Kee Ming Chia, Ji Liu

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 3.50 MB

english, 2011

26

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort

Eunjung Lee, Fredrick Schumacher, Juan Pablo Lewinger, Susan L Neuhausen, Hoda Anton-Culver, Pamela L Horn-Ross, Katherine D Henderson, Argyrios Ziogas, David Van Den Berg, Leslie Bernstein, Giske Urs

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 309 KB

english, 2011

27

Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy

Wei Zhang, Aldo Becciolini, Annibale Biggeri, Paolo Pacini, Colin R Muirhead

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 270 KB

english, 2011

28

miR-24-2 controlsH2AFXexpression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic geneBCL-2: a potential for therapeutic intervention

Niloo Srivastava, Siddharth Manvati, Archita Srivastava, Ranjana Pal, Ponnusamy Kalaiarasan, Shilpi Chattopadhyay, Sailesh Gochhait, Raina Dua, Rameshwar NK Bamezai

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 2.19 MB

english, 2011

29

Exploring the link betweenMORF4L1and risk of breast cancer

Griselda Martrat, Christopher A Maxwell, Emiko Tominaga, Montserrat Porta-de-la-Riva, Núria Bonifaci, Laia Gómez-Baldó, Massimo Bogliolo, Conxi Lázaro, Ignacio Blanco, Joan Brunet, Helena Aguilar, Jua

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 2.31 MB

english, 2011

30

Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential

Frances S Kittrell, Martha Z Carletti, Sofia Kerbawy, Jessica Heestand, Wa Xian, Mei Zhang, Heather L LaMarca, Arnoud Sonnenberg, Jeffrey M Rosen, Daniel Medina, Fariba Behbod

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 4.82 MB

english, 2011

31

Genetic variation inPRLandPRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland

Sarah J Nyante, Jessica M Faupel-Badger, Mark E Sherman, Ruth M Pfeiffer, Mia M Gaudet, Roni T Falk, Abegail A Andaya, Jolanta Lissowska, Louise A Brinton, Beata Peplonska, Barbara K Vonderhaar, Steph

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 342 KB

english, 2011

32

Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action

Lisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, Gordon Parry, Laurie Goodman, John Winslow

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 843 KB

english, 2011

33

Targets of miR-200c mediate suppression of cell motility and anoikis resistance

Erin N Howe, Dawn R Cochrane, Jennifer K Richer

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 9.20 MB

english, 2011

34

Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cellsin vivo

Mark Barok, Minna Tanner, Katri Köninki, Jorma Isola

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.88 MB

english, 2011

35

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers

Max Yan, Nicholas Jene, David Byrne, Ewan KA Millar, Sandra A O’Toole, Catriona M McNeil, Gaynor J Bates, Adrian L Harris, Alison H Banham, Robert L Sutherland, Stephen B Fox

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 1.94 MB

english, 2011

36

Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer

Lesa A Tran,Lon J Wilson

Journal:

Breast Cancer Research

Year:

2011

Language:

english

File:

PDF, 124 KB

english, 2011